Two Sigma Advisers’s TherapeuticsMD TXMD Stock Holding History

Two Sigma Advisers’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4,694	Closed	-$83K	–	2908
2021 Q4	$83K	Buy	4,694 +1,628	+53%	+$48.8K	﹤0.01%	2432
2021 Q3	$114K	Buy	+3,066	New	+$136K	﹤0.01%	2315
2021 Q2	–	Sell	-3,034	Closed	-$203K	–	2704
2021 Q1	$203K	Buy	+3,034	New	+$237K	﹤0.01%	2353
2020 Q3	–	Sell	-3,388	Closed	-$212K	–	2635
2020 Q2	$212K	Buy	3,388 +1,782	+111%	+$104K	﹤0.01%	2231
2020 Q1	$85K	Sell	1,606 -830	-34%	-$82.3K	﹤0.01%	2318
2019 Q4	$295K	Buy	+2,436	New	+$350K	﹤0.01%	2071
2016 Q4	–	Sell	-574	Closed	-$195K	–	2456
2016 Q3	$195K	Buy	+574	New	+$210K	﹤0.01%	2050

Other funds holding TXMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Two Sigma Advisers's TXMD Position: Q1 2022 in Review

Two Sigma Advisers sold out of TherapeuticsMD (TXMD) in Q1 2022, closing a stake of 4,694 shares — an estimated $83K sold.

Two Sigma Advisers first reported a position in TXMD in Q3 2016 and held it in 7 quarters. The position peaked at $295K in Q4 2019. 124 funds tracked by Wall St. Rank hold TXMD as of Q1 2022.

Two Sigma Advisers reported no remaining TherapeuticsMD position as of Q1 2022 after selling out during the quarter.
Two Sigma Advisers sold 4,694 TherapeuticsMD shares in Q1 2022, an estimated $83K.
Two Sigma Advisers first reported a position in TherapeuticsMD in Q3 2016 and held it in 7 quarters.
Two Sigma Advisers's TherapeuticsMD position peaked at $295K in Q4 2019.
124 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2022.

Based on Two Sigma Advisers's 13F filing for Q1 2022, filed 16 May 2022.